Arcus Biosciences, Inc. (RCUS) › Capital ExpendituresArcus Biosciences, Inc. (RCUS) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $4.10M2017: $5.51M2018: $3.74M2019: $1.93M2020: $3.00M2021: $26.00M2022: $6.00M2023: $24.00M2024: $6.00M2025: $2.00M$2.00M2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$2.00M-66.7%2024$6.00M-75.0%2023$24.00M+300.0%2022$6.00M-76.9%2021$26.00M+766.7%2020$3.00M+55.8%2019$1.93M-48.6%2018$3.74M-32.1%2017$5.51M+34.5%2016$4.10M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share